Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study
about
Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic.Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.Reduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis and systematic reviewDoes iron overload really matter in stem cell transplantation?A disease risk index for patients undergoing allogeneic stem cell transplantation.Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid MalignanciesOutcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem cell transplantation.Lymphoblastic lymphoma in childhood and adolescence.Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how.Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.Immunotherapy in acute myeloid leukemia.Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients.Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation.Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation.Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8.Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission.Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.Long-term outcome of HLA-haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion based on an FBCA conditioning regimen for hematologic malignancies.European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR.Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index.
P2860
Q33566684-E5EBB23C-541D-462A-939F-1D3F255097B5Q33718837-AC542005-0F15-4C5C-81F7-F4E7B1ECFAE7Q34684038-7F88CF5D-6143-4711-9818-1A0D8562FD6DQ34770016-C74A8F6C-C4A2-47A3-AC2F-5EBB01614FF6Q35981569-6CB42B77-11AC-4CCA-86D0-1C8FF68B988DQ36141944-050A011B-F3AE-42A5-A7ED-09CF3B42E9F2Q36474066-D3663026-68DA-46B1-8D25-6C84AC5E335DQ37359736-8B8332AF-325A-4F33-989D-1DD3735C2BB6Q38102065-103E3BA5-219E-4D56-94BC-8A3C71F044C9Q38130168-982F8CB8-67B3-4783-8978-07EE236EDD3CQ38207595-9D550A77-8D41-4AF8-87E1-C5FEFFD6C1CBQ38533606-AD6C6A26-4FF6-4BFC-9AEB-818E4D674CE3Q38657161-B092DF43-9850-401C-A5F6-03914DCD1D11Q38858092-4A0361CD-01AE-4F0C-AFCF-07157ADD5F82Q38926882-6563F596-608C-4B4D-B582-AEC9F83CA7DAQ39036994-1118F6AC-1130-4ADD-B727-9B3145E2696EQ41141397-1509CF1A-2464-4448-9588-5BD2C632020DQ41564670-9940CB60-CC49-4B83-9C9E-9A8E93C15C42Q41592261-818278D9-3EE9-4AD0-AED8-0E51CE8F00C8Q41747328-790C64A2-684E-43E4-8AD6-F217272D8B55Q42616605-21AB772C-FB92-4C6A-BE1B-5F1B43F44C91Q42705413-7DDF16D3-9CC8-4A38-9C42-B19A3D9385C7Q45233774-03AE4A3B-9DA2-48A8-B022-018EB87687FFQ45774394-FDF0F4DA-7E07-48B1-A0AA-453567248187Q52881816-C9FD7CFC-DE10-4F43-99DB-FB6B07E94510
P2860
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Classifying cytogenetics in pa ...... rrow Transplant Research study
@ast
Classifying cytogenetics in pa ...... rrow Transplant Research study
@en
type
label
Classifying cytogenetics in pa ...... rrow Transplant Research study
@ast
Classifying cytogenetics in pa ...... rrow Transplant Research study
@en
prefLabel
Classifying cytogenetics in pa ...... rrow Transplant Research study
@ast
Classifying cytogenetics in pa ...... rrow Transplant Research study
@en
P2093
P2860
P1476
Classifying cytogenetics in pa ...... rrow Transplant Research study
@en
P2093
Alan M Miller
Andrew S Artz
Ann A Jakubowski
Bipin N Savani
Bruce M Camitta
Chadi Nabhan
Christopher N Bredeson
Corey S Cutler
Daniel J Weisdorf
David I Marks
P2860
P304
P356
10.1016/J.BBMT.2011.07.024
P577
2011-07-31T00:00:00Z